Krista Davis's most recent trade in ANI Pharmaceuticals Inc was a trade of 1,763 Common Stock done at an average price of $91.1 . Disclosure was reported to the exchange on Aug. 22, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ANI Pharmaceuticals Inc | Krista Davis | SVP, CHIEF HR OFFICER | Sale of securities on an exchange or to another person at price $ 91.10 per share. | 22 Aug 2025 | 1,763 | 62,896 (0%) | 0% | 91.1 | 160,609 | Common Stock |
| ANI Pharmaceuticals Inc | Krista Davis | SVP, CHIEF HR OFFICER | Sale of securities on an exchange or to another person at price $ 65.00 per share. | 19 Mar 2025 | 1,866 | 64,659 (0%) | 0% | 65 | 121,290 | Common Stock |
| ANI Pharmaceuticals Inc | Krista Davis | SVP, CHIEF HR OFFICER | Sale of securities on an exchange or to another person at price $ 60.86 per share. | 07 Mar 2025 | 1,000 | 66,525 (0%) | 0% | 60.9 | 60,860 | Common Stock |
| ANI Pharmaceuticals Inc | Krista Davis | SVP, CHIEF HR OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.89 per share. | 28 Feb 2025 | 1,099 | 67,525 (0%) | 0% | 61.9 | 68,017 | Common Stock |
| ANI Pharmaceuticals Inc | Krista Davis | SVP, CHIEF HR OFFICER | Sale of securities on an exchange or to another person at price $ 60.20 per share. | 21 Feb 2025 | 1,000 | 68,624 (0%) | 0% | 60.2 | 60,200 | Common Stock |
| ANI Pharmaceuticals Inc | Krista Davis | SVP, CHIEF HR OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 13,057 | 62,116 (0%) | 0% | 0 | Common Stock | |
| ANI Pharmaceuticals Inc | Krista Davis | SVP, CHIEF HR OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 8,704 | 70,820 (0%) | 0% | 0 | Common Stock | |
| ANI Pharmaceuticals Inc | Krista Davis | SVP, CHIEF HR OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.92 per share. | 12 Feb 2025 | 1,196 | 69,624 (0%) | 0% | 58.9 | 70,468 | Common Stock |
| ANI Pharmaceuticals Inc | Krista Davis | SVP, CHIEF HR OFFICER | Sale of securities on an exchange or to another person at price $ 60.00 per share. | 11 Dec 2024 | 1,000 | 49,059 (0%) | 0% | 60 | 60,000 | Common Stock |
| ANI Pharmaceuticals Inc | Krista Davis | SVP, CHIEF HR OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 56.15 per share. | 12 Sep 2024 | 1,486 | 50,059 (0%) | 0% | 56.2 | 83,439 | Common Stock |
| ANI Pharmaceuticals Inc | Krista Davis | SVP, CHIEF HR OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.67 per share. | 29 Feb 2024 | 1,173 | 51,545 (0%) | 0% | 67.7 | 79,377 | Common Stock |
| ANI Pharmaceuticals Inc | Krista Davis | SVP, CHIEF HR OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 12,079 | 44,666 (0%) | 0% | 0 | Common Stock | |
| ANI Pharmaceuticals Inc | Krista Davis | SVP, CHIEF HR OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 8,052 | 52,718 (0%) | 0% | 0 | Common Stock | |
| ANI Pharmaceuticals Inc | Krista Davis | SVP, CHIEF HR OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 12,158 | 28,591 (0%) | 0% | 0 | Common Stock | |
| ANI Pharmaceuticals Inc | Krista Davis | SVP, CHIEF HR OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 8,104 | 36,695 (0%) | 0% | 0 | Common Stock | |
| ANI Pharmaceuticals Inc | Krista Davis | SVP, CHIEF HR OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2022 | 16,433 | 16,433 (0%) | 0% | 0 | Common Stock |